International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia (Q44014892)
Jump to navigation
Jump to search
scientific article published on 19 May 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia |
scientific article published on 19 May 2014 |
Statements
1 reference
International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia (English)
1 reference
1 reference
Gail J Roboz
1 reference
Todd Rosenblat
1 reference
Martha Arellano
1 reference
Marco Gobbi
1 reference
Jessica K Altman
1 reference
Pau Montesinos
1 reference
Casey O'Connell
1 reference
Scott R Solomon
1 reference
Arnaud Pigneux
1 reference
Norbert Vey
1 reference
Tove Flem Jacobsen
1 reference
Athos Gianella-Borradori
1 reference
Øivind Foss
1 reference
Sylvia Vetrhusand
1 reference
Francis J Giles
1 reference
19 May 2014
1 reference
1 reference
32
1 reference
18
1 reference
1919-1926
1 reference
Identifiers
1 reference
1 reference